Content and data provided by various third parties and Fidelity − Terms of Use

Stock Details

RELATED RESOURCES

News & Events:CMLS

CUMULUS MEDIA INC

8.48Down -0.37 (-4.1808 %)as of 4:00:00pm ET 08/05/2022

Quotes delayed at least 15 min. Log in for real time quote.

Log in for more news Show all article details.Expand all| Hide all article details.Collapse all
  1. Show article details.

    BRIEF-Cumulus Media Reports Q2 EPS Of $0.42

    Reuters – 5:39 PM ET 08/03/2022

    Cumulus Media Inc (CMLS): * QTRLY EARNINGS PER SHARE $0.42. * CUMULUS MEDIA REPORTS OPERATING RESULTS FOR THE SECOND QUARTER 2022. * Q2 REVENUE $236.7 MILLION Further company coverage:
  2. Show article details.

    Cumulus Media Reports Operating Results for the Second Quarter 2022

    GlobeNewswire – 4:01 PM ET 08/03/2022

    Delivers Strong Results with Total Revenue Up 5% Led by Digital Revenue Growth of 20% Recorded Net Income of $8.7 Million and EBITDA of $45.5 Million Completed $25 Million Dutch Tender and Retired $50 Million of Debt ATLANTA, Aug. 03, 2022 -- Cumulus Media Inc. (CMLS) today announced operating results for the three and six months ended June 30, 2022.
  3. Show article details.

    Earnings Scheduled For August 3, 2022

    Benzinga – 7:30 AM ET 08/03/2022

      ** Fresh Del Monte Produce is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion. ** Cohen & Co is expected to report earnings for its second quarter. ** Standard Motor Products is expected to report quarterly earnings at $1.18 per share on revenue of $356.59 million.
  4. Show article details.

    Earnings Scheduled For August 3, 2022

    Benzinga – 4:30 AM ET 08/03/2022

      ** Fresh Del Monte Produce is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion. ** Cohen & Co is expected to report earnings for its second quarter. ** Standard Motor Products is expected to report quarterly earnings at $1.18 per share on revenue of $356.59 million.
  5. Show article details.

    Cumulus Media Pioneers Data-Driven Targeting Via Swoop for Broadcast Radio Pharmaceutical Brand Campaigns

    GlobeNewswire – 4:04 PM ET 08/01/2022

    Study Underscores Broadcast Radio’s Advertising Value for Pharmaceutical Brands First-Ever Historic Study Combines a Modeled Patient Segment from Swoop with Nielsen Audio AM/FM Radio Listening Data NEW YORK, Aug. 01, 2022 --  The Cumulus Media (CMLS) | Westwood One Audio Active Group® today announced a new capability for pharmaceutical brands developed with data from precision healthcare marketing exp...
  6. Show article details.

    Stocks That Hit 52-Week Lows On Friday

    Benzinga – 11:40 AM ET 07/15/2022

      On Friday, 137 stocks made new 52-week lows. The following stocks created new 52-week lows on Friday:   Be sure to monitor Benzinga for the news traders need!
  7. Show article details.

    Cumulus Media Announces Conference Call to Discuss Second Quarter 2022 Operating Results

    GlobeNewswire – 4:01 PM ET 07/14/2022

    Cumulus Media Inc. (CMLS) will host a conference call on Wednesday, August 3rd at 4:30 PM ET to discuss its second quarter 2022 operating results. To participate in the conference call, please register in advance using this link. The conference call will also be broadcast live in listen-only mode through a link on the Company’s investor relations website at www.cumulusmedia.com/investors.
  8. Show article details.

    Stocks That Hit 52-Week Lows On Thursday

    Benzinga – 12:09 PM ET 07/14/2022

      On Thursday, 550 companies achieved new lows for the year. The stocks that set new 52-week lows on Thursday: Be sure to stay with Benzinga for further updates and market-moving news.
  9. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 12:22 PM ET 07/13/2022

      During Wednesday's session, 326 stocks hit new 52-week lows. The following stocks created new 52-week lows on Wednesday: Be sure to stay with Benzinga for further updates and market-moving news.
  10. Show article details.

    Cumulus Media Debuts Talk Ville, A “Smallville” Television Show Re-Watch Podcast With Series Stars Tom Welling and Michael Rosenbaum

    GlobeNewswire – 2:05 PM ET 07/06/2022

    Cumulus Media  welcomes Talk Ville to the Cumulus Podcast Network on July 13, 2022. A new episode of Talk Ville will drop each subsequent Wednesday and be available at Apple Podcasts, Spotify, Stitcher, TuneIn, Pocket Casts, and Google Podcasts, among other platforms. “I'm glad we're finally able to do this!
  11. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 12:39 PM ET 06/29/2022

      During Wednesday's session, 340 companies made new 52-week lows. Stocks that set new 52-week lows on Wednesday are as follows: Be sure to stay with Benzinga for further updates and market-moving news.
  12. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 12:30 PM ET 06/22/2022

      On Wednesday, 329 companies hit new 52-week lows. Here are all the stocks that set new 52-week lows on Wednesday: Be sure to monitor Benzinga for the news traders need!
  13. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 12:22 PM ET 06/15/2022

      Wednesday's session saw 269 companies set new 52-week lows. Here are all the stocks that set new 52-week lows on Wednesday: Be sure to monitor Benzinga for the news traders need!
  14. Show article details.

    Stocks That Hit 52-Week Lows On Tuesday

    Benzinga – 12:11 PM ET 06/14/2022

      On Tuesday, 951 companies hit new 52-week lows. On Tuesday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.
  15. Show article details.

    93 Biggest Movers From Yesterday

    Benzinga – 3:58 AM ET 06/14/2022

  16. Show article details.

    70 Stocks Moving In Monday's Mid-Day Session

    Benzinga – 12:10 PM ET 06/13/2022

     Gainers Day One Biopharmaceuticals, Inc. shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%. Hillstream BioPharma, Inc. jumped 84% to $1.4713 after it authorized a share repurchase program to acquire up to $1 million in common stock.
  17. Show article details.

    Cumulus Media Announces Final Results of Tender Offer

    GlobeNewswire – 5:00 PM ET 06/09/2022

    Cumulus Media Inc. (CMLS) today announced the final results of its "modified Dutch auction" tender offer, which expired at midnight, New York City time, on June 3, 2022.
  18. Show article details.

    BRIEF-Cumulus Media Announces Extension Of Existing ABL Credit Facility

    Reuters – 4:02 PM ET 06/08/2022

    Cumulus Media Inc (CMLS): * CUMULUS MEDIA ANNOUNCES EXTENSION OF EXISTING ABL CREDIT FACILITY. * Cumulus Media Inc (CMLS) - UNIT ENTERED INTO AN AMENDMENT OF ITS EXISTING $100 MILLION REVOLVING CREDIT FACILITY. * Cumulus Media Inc (CMLS) - AMENDMENT, AMONG OTHER THINGS, EXTENDS MATURITY FROM 2025 TO 2027 SUBJECT TO CERTAIN SPRINGING MATURITY CONDITIONS Source text for Eikon: Further company coverage:
  19. Show article details.

    Cumulus Media Announces Extension of Existing ABL Credit Facility

    GlobeNewswire – 4:00 PM ET 06/08/2022

    Cumulus Media Inc. (CMLS) today announced that Cumulus Media New Holdings Inc., its indirect wholly owned subsidiary, entered into an amendment of its existing $100 million revolving credit facility.
  20. Show article details.

    Cumulus Media Names Lisa Waks Senior Vice President, Digital Partnerships and Business Development

    GlobeNewswire – 9:45 AM ET 06/08/2022

    Cumulus Media (CMLS) today announced that Lisa Waks has joined the company as Senior Vice President, Digital Partnerships and Business Development, leading Cumulus Podcast Network’s content acquisition strategy and content pipeline development, with a focus on personality-driven brand franchises in the News; Business, Money & Tech; Sports; and Entertainment verticals.
Page:

Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

  • Aug
    03

    CMLS announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Classic Patterns (past 90 days)

PROVIDED BY RECOGNIA, INC.

View All Technical Analysis in Advanced Chart Opens in New Window

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
Copyright 1998–2022 FMR LLC. 
All rights reserved. 
Close
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.